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Research Letter
The impact of perinatal severe acute respiratory
syndrome coronavirus 2 infection during the
peripartum period
OBJECTIVE:
Our large integrated health system in New
York City implemented universal screening for infection with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the virus causing the coronavirus disease 2019 (COVID19) pandemic in 2019 and 2020, of all women admitted to the
labor service on March 25, 2020. We also implemented universal screening of all neonates born to mothers who were
SARS-CoV-2 positive. Here, we report perinatal SARS-CoV-2
infection outcomes in our population during the complete
peak period of the COVID-19 incidence and inpatient
volume in the New York City area, March 25, 2020, to May
15, 2020. We also describe how perinatal SARS-CoV-2 was
tracked with the number of COVID-19 hospitalizations in
our hospitals. This information is critically important in
planning for future COVID-19 outbreaks either in regions
previously minimally impacted by the virus or in an
anticipated future resurgence. This study aimed to assess
the impact of SARS-CoV-2 on delivery and postpartum
services in a single health system in New York City during
the peak period of the COVID-19 pandemic. Speciﬁcally,
we were interested in the clinical impact of SARS-CoV-2
infection on the adverse pregnancy outcomes of stillbirth
and preterm birth during the peak period of the pandemic.
We were also interested in the volume of patients who were
SARS-CoV-2 positive presenting to our labor ﬂoors
compared with the volume of COVID-19 admissions to
other hospital services as we prepare for a possible second
wave of the pandemic this fall. Our goal with this study was
to provide data necessary for such service preparedness.

We retrospectively identiﬁed women
testing positive on a single admission polymerase chain reaction test for SARS-CoV-2 during the period of interest by
automated query of the electronic medical record. We then
abstracted the maternal and infant medical records for
relevant demographic and clinical data, with particular
attention to the adverse outcomes of interest intrauterine
fetal demise (IUFD) at 22 weeks’ gestation and preterm
birth before 37 weeks’ gestation. Because our study sample
was drawn from available clinical data, we also conducted
power calculations to determine the sample size that would
be needed to deﬁnitively assess the impact of SARS-CoV-2
infection on preterm birth and IUFD with a power of 0.8
with an a of 0.05. Inpatient COVID-19 admission volume
during the period of interest was obtained from
deidentiﬁed hospital operation data that were published to
health system employees daily during the period of interest.
The volume of obstetrical patients who were SARS-CoV-2
STUDY DESIGN:

positive was compared with the COVID-19 hospitalization
data using the chi-square test and Pearson correlation. This
study was approved by the Mount Sinai Program for the
Protection of Human Subjects.
Here, 1794 women delivered 1830 live infants
during the study period. Our population was diverse; 16.2%
identiﬁed themselves as black, 17.4% as Asian, and 16.4% as
Hispanic. Furthermore, 180 women tested positive for SARSCoV-2 on labor ﬂoor admission Up to 28% of women
admitted to the labor ﬂoors each day tested positive for
SARS-CoV-2 with a median of 8% (interquartile range, 0%
e14%) of patients in the labor ﬂoor testing positive for
SARS-CoV-2 daily during the period of interest. Of these
patients, 7 (3.9%) had severe disease requiring intensive care,
37 (20.6%) required some respiratory support, and 136
(75.6%) were mildly symptomatic or asymptomatic. Risk
factors of severe COVID-19 were present in many of our
patients in the labor ﬂoor: 9.8% had pregestational or
gestational diabetes mellitus; furthermore, 35.5% had a body
mass index (BMI) of >30, and 5.7% had a BMI of >40 at
the time of delivery. No neonate demonstrated illness
consistent with COVID-19, however 3 tested positive for
SARS-CoV-2 following birth. From January through June
2020, the preterm birth rate among SARS-CoV-2 positive
mothers was 8.2%, compared to a preterm birth rate among
SARS-CoV-2 negative mothers of 7.5% (P¼.74). Only 4
preterm births to mothers who were SARS-CoV-2 positive
occurred prior to 35 weeks’ gestation. Of note, 1 of these
births before 35 weeks’ gestation was spontaneous, 2 were
deliveries for severe maternal COVID-19, and 1 was for
vaginal bleeding in the setting of placenta previa. There were
14 IUFDs (0.76% of births) during the peak period of the
pandemic. This was not statistically different from the 15
IUFDs (0.84% of births) at our hospitals during January
2020 to June 2020 (P¼1). During the peak period of the
pandemic, there were 2 IUFDs among asymptomatic patients
who were SARS-CoV-2 positive and 12 among patients who
were SARS-CoV-2 negative (1.11% vs 0.86%; P¼.35). All
IUFDs occurred before arrival to the hospital, and none were
attributed to SARS-CoV-2 infection by the clinical teams.
Although 1 patient reported delaying prenatal care because of
fear of contracting COVID-19 through contact with the
healthcare system, all remaining patients reported normal
frequency of contact with prenatal care providers. Some of
these contacts were via telehealth, whereas before the COVID19 pandemic, all visits would have been ofﬁce visits. We
conducted 2 power calculations, one to determine the sample
RESULTS:
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FIGURE 1

Hospitalized SARS-CoV-2epositive patients by admitting unit

COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Janssen. Impact of perinatal severe acute respiratory syndrome coronavirus 2. AJOG MFM 2021.
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FIGURE 2

SARS-CoV-2epositive patients admitted to the labor floor

SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Janssen. Impact of perinatal severe acute respiratory syndrome coronavirus 2. AJOG MFM 2021.

size needed to conclusively determine the impact of SARS-CoV-2
infection on preterm birth and a second to determine that
needed for IUFD. Based on the observed incidence of events
in our population, 12,710 obstetrical patients who were SARSCoV-2 positive and 113,971 obstetrical patients who were
SARS-CoV-2 negative would be needed to detect a difference
in preterm birth rate, and 287 obstetrical patients who were
SARS-CoV-2 positive and 2567 obstetrical patients who were
SARS-CoV-2 negative would be needed to detect a difference
in IUFD. The number of women who were SARS-CoV-2
positive on the obstetrical service was 0.26%0.002% of the
number of patients admitted to our hospitals with COVID-19
(Pearson r¼0.61). The number of obstetrical SARS-CoV-2

cases did not correlate as closely with COVID-19 intensive
care unit (ICU) admissions (Pearson r¼0.49) as with the total
number of patients admitted to our hospitals (ﬂoor and ICU
beds) with COVID-19. Figure 1 demonstrates the relationship
between SARS-CoV-2 infection in the labor and delivery
population and the overall number of patients with COVID-19
admitted to our hospitals and ICUs. Figure 2 shows only
obstetrical patients who were SARS-CoV-2 positive.
Our experience with COVID-19 in the
perinatal population was similar to that previously reported by
other hospitals in the Northeast.1,2 As reported in part
elsewhere,3 most of these women were mildly symptomatic or

CONCLUSION:
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asymptomatic. In this study, we examined the adverse pregnancy
outcomes of preterm birth and stillbirth during the peak period
of the pandemic in our region, as there has been concern that
COVID-19 may increase these outcomes.4 We chose to
compare the peak period of the pandemic in our region,
March 25, 2020, to May 15, 2020, with low prevalence months
of January 2020 to June 2020. We did not evaluate the
outcomes in February 2020 to early March 2020 as poor
availability of testing meant that SARS-CoV-2 was likely
spreading undetected in our region during that period. The
rate of preterm birth among women who were SARS-CoV-2
positive was lower than both the national preterm birth rate of
10.02%5 and among women who were SARS-CoV-2 negative.
In addition, the number of preterm births before 35 weeks’
gestation, those at highest risk of child morbidity related to
prematurity, was exceedingly low. These data are reassuring.
Only 3 infants born to a mother who was SARS-CoV-2
positive tested positive for SARS-CoV-2, and none were
clinically ill. As in other similar reported cases,6,7 those
infections were believed to be due to horizontal transmission.
The rate of stillbirth among women who were SARS-CoV-2
positive was not signiﬁcantly higher than the rate of stillbirth
among women who were SARS-CoV-2 negative. In addition,
there was no increase in the number of stillbirths during the
peak period of the pandemic. Our study’s strength, the
availability of testing in the entire population of interest, may
explain the differing results from a recent report drawn from a
population that tested only women with symptoms of
COVID-19.6 Unlike that report, we did not ﬁnd an increase in
stillbirth related to COVID-19, likely because we were able to
correctly classify women without symptoms and women with
mild symptoms by SARS-CoV-2 status. Another strength of
our study is the diverse nature of our patient population with
representative rates of risk factors of severe COVID-19.
Although our study was conducted in a large health system
signiﬁcantly impacted by the COVID-19 pandemic, we
encountered only a small absolute number of obstetrical
patients with SARS-CoV-2 infection. Our power calculations
indicated that deﬁnitive answers to the question of impact of
SARS-CoV-2 infection on perinatal outcomes could be
determined from a national registry. Although a minority of
the cases of COVID-19 in the perinatal population required
high-acuity care, the resources needed to care for women and
babies during the COVID-19 pandemic were signiﬁcant.
Personal protective equipment (PPE) needs were high as all
women admitted to the labor ﬂoor were presumed positive
until testing results returned and as vaginal delivery was
considered an aerosolizing procedure. Extra pediatric staff
were needed for neonatal resuscitation because of the time
involved in donning PPE. Signiﬁcant policy changes around
family visitation were needed to accommodate the high
prevalence of SARS-CoV-2 in our community. The need for
private rooms and isolation nurseries for families who were
SARS-CoV-2 positive outstripped availability rapidly, especially
on days when a large percentage of obstetrical patients tested
positive. This resulted in a shortening of the standard
4 AJOG MFM JANUARY 2021

postpartum stay to 24 hours. Because predictions of hospital
and ICU admissions are readily available data in most
communities, extrapolation from these data is useful in
predicting the needs of perinatal services facing rising
community COVID-19. Although there was a day-to-day
variation, the number of obstetrical patients with SARS-CoV-2
strongly correlated with the number of patients hospitalized
with COVID-19 through the peak period of the pandemic.
There was no increase in preterm birth or stillbirth rates
related to SARS-CoV-2 infection. The number of women who
were SARS-CoV-2 positive admitted to the labor ﬂoor
correlated with the number of COVID-19 admissions to other
hospital services.
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